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To sense its population density and to trigger entry into the
stress-resistant dauer larval stage, Caenorhabditis elegans uses
the dauer pheromone, which consists of ascaroside derivatives with short, fatty acid-like side chains. Although the dauer
pheromone has been studied for 25 years, its biosynthesis is
completely uncharacterized. The daf-22 mutant is the only known
mutant defective in dauer pheromone production. Here, we show
that daf-22 encodes a homolog of human sterol carrier protein
SCPx, which catalyzes the final step in peroxisomal fatty acid
␤-oxidation. We also show that dhs-28, which encodes a homolog
of the human D-bifunctional protein that acts just upstream of
SCPx, is also required for pheromone production. Long-term daf-22
and dhs-28 cultures develop dauer-inducing activity by accumulating less active, long-chain fatty acid ascaroside derivatives. Thus,
daf-22 and dhs-28 are required for the biosynthesis of the shortchain fatty acid-derived side chains of the dauer pheromone and
link dauer pheromone production to metabolic state.
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nder favorable growth conditions, including low population
density and high food availability, the nematode Caenorhabditis elegans progresses from the egg through 4 larval stages
(L1 to L4) to the reproductive adult stage. However, if an L1
larva encounters high population density and low food availability, it will develop into an alternative L3 larval stage, the
dauer (1–3). The dauer larva accumulates excess fat, its pharynx
becomes sealed from the environment, and its cuticle becomes
thicker, enabling it to survive harsh environmental conditions
for prolonged periods. Dauer formation is controlled by multiple
signaling pathways, including the transforming growth factor
TGF␤ (4–7) and the insulin/insulin-like growth factor IGF-1
(8–12) signaling pathways that converge on the DAF-12 nuclear
hormone receptor (13–18), which is expressed in many of the
tissues that undergo remodeling during dauer formation (19).
C. elegans senses its population density by a small-molecule
pheromone, the dauer pheromone, which it continually secretes
into its environment. More than 25 years ago, Golden and Riddle
provided the first evidence for the dauer pheromone by showing
that the ‘‘conditioned medium’’ from densely grown cultures of
C. elegans could be used both to induce dauer formation and to
inhibit dauer recovery (2, 3, 20). A crude dauer pheromone
extract could be generated by drying down the conditioned
medium and extracting the dried residue with organic solvent. By
using activity-guided fractionation and NMR-based structure
elucidation, the dauer pheromone has recently been shown
to consist of several derivatives of the dideoxysugar ascarylose
(21– 23). The ascarosides differ only in the identity of the fatty
acid-like side chain, and thus, we refer to them based on the
carbon length of the side chains as ascaroside C6 (1) (22),
ascaroside C9 (2) (22), ascaroside C3 (3) (23), and the much less
potent ascaroside C7 (4) (21) (Fig. 1A).
The daf-22 mutant was originally identified as a mutant that
fails to produce active conditioned medium that inhibits dauer
recovery (24). No pheromone activity was detected in either the
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Fig. 1. Implicating DAF-22 and DHS-28 in dauer pheromone production. (A)
The structures of the dauer pheromone components, ascaroside C6 (1), ascaroside C9 (2), ascaroside C3 (3), and the less active ascaroside C7 (4). (B) Gene
structures of daf-22 and dhs-28. hj4 harbors the same lesion as the original
daf-22 allele m130. ok693 is a deletion allele. The corresponding amino acid
changes for each allele are shown. (C) The noninducible peroxisomal pathway
for fatty acid ␤-oxidation. DHS-28 is homologous to human D-bifunctional
protein, and DAF-22 is homologous to human SCPx thiolase.

daf-22 conditioned medium or in organic extracts of the daf-22
worms themselves. Interestingly, the conditioned medium from
daf-22 cultures did gradually develop the ability to inhibit dauer
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Fig. 2. Comparison of the dauer-inducing activity in short-term and long-term cultures of wild-type, daf-22 and dhs-28 strains. (A) The dauer-inducing activity
of worm and conditioned medium extracts from short-term (10 d) wild-type, daf-22 and dhs-28 cultures. The data represent the average of 2 experiments (⫾1
SD). (B) The dauer-inducing activity of worm and conditioned medium extracts from long-term (20 d) wild-type, daf-22 and dhs-28 cultures. The data represent
the average of 2 experiments (⫾1 SD). (C) The chemical structures of the long-chain ascarosides from conditioned medium extracts from long-term dhs-28
cultures. The structural assignment of long-chain ascaroside 17 is tentative.

recovery if the cultures were grown for extended periods (24). In
addition, if aqueous extracts from lysed adult daf-22 worms were
incubated for extended periods at room temperature, they
developed pheromone activity over time (D. Riddle, personal
communication). This evidence led to the speculation that either
(i) the daf-22 mutant could not secrete/excrete the dauer pheromone or (ii) the daf-22 mutant was able to synthesize some
inactive precursor of the dauer pheromone that over time was
processed to the dauer pheromone.
Here, we implicate 2 genes involved in fatty acid ␤-oxidation
in dauer pheromone biosynthesis—daf-22 that encodes a homolog of the thiolase domain of human SCPx and dhs-28 that
encodes a homolog of the dehydrogenase domain of human
D-bifunctional protein. Extended culture of these strains results
in the accumulation of dauer-inducing long-chain ascarosides,
both in the worms themselves and in the culture medium. Thus,
these strains are defective not in pheromone secretion/excretion,
but rather pheromone biosynthesis, and produce an alternative
set of weakly active, dauer-inducing molecules that accumulate
over time. Additionally, both daf-22 and dhs-28 are expressed in
the intestine, which is likely the site of pheromone biosynthesis.
Results
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Cloning of daf-22 and dhs-28. A fluorescently labeled fatty acid

analog, C1-BODIPY-C12, has been used to monitor fat storage
in live C. elegans animals (25, 26). In a forward genetic screen for
fat-storage mutants that showed abnormal C1-BODIPY-C12
staining, we isolated multiple alleles that fell into 4 complementation groups. Here, we report the cloning of mutants from two
of them. The first complementation group includes hj1, hj2, hj3,
and hj4, and was mapped to chromosome II close to the genetic
interval where daf-22 resided. Transgenic rescue and sequencing
experiments led to the identification of a single ORF,
Y57A10C.6, which harbored mutations in hj1, hj2, hj3, hj4, and
m130, the canonical allele of daf-22 (Fig. 1B). Sequence analysis
(supporting information (SI) Fig. S1 A) suggests that daf-22
encodes a thiolase that is homologous to the thiolase domain of
1876 兩 www.pnas.org兾cgi兾doi兾10.1073兾pnas.0810338106

mammalian SCPx, a peroxisomal 3-ketoacyl-CoA thiolase that
participates in straight-chain and branched-chain fatty acid
␤-oxidation and processing of bile acids (27) (Fig. 1C). Based on
genetic mapping and transgenic rescue experiments (data not
shown), we determined that the second complementation group,
including hj5, hj6, hj7, and hj8, defined dhs-28 (Fig. 1B). dhs-28
encodes a dehydrogenase that shares greatest homology with the
dehydrogenase domain of mammalian perox isomal D bifunctional protein, which acts upstream of SCPx (see Fig. S1B).
We therefore speculated that DHS-28 may also act upstream of
DAF-22 in C. elegans and asked whether they are part of a
biosynthetic pathway for the production of dauer pheromone.
Characterization of Short-Term Cultures of daf-22 and dhs-28 Worms.

To study whether the dauer pheromone is produced by daf-22
and dhs-28 worms, wild-type, daf-22, and dhs-28 worms were
grown in liquid culture until just after the Escherichia coli food
source had been exhausted (10 d). The worms were filtered from
the conditioned medium and washed, and both the worms and
the conditioned medium were collected, freeze dried, and
extracted with ethanol. Unlike the extracts obtained from wildtype cultures, the worm and conditioned medium extracts obtained from the daf-22 and dhs-28 cultures did not show any
dauer-inducing activity in a dauer formation assay, in which the
extracts were incorporated into an agar plate on which eggs were
allowed to hatch and develop and dauer formation was monitored (Fig. 2A). The worm and conditioned medium extracts
from the wild-type, daf-22, and dhs-28 cultures were compared
by liquid chromatography mass spectrometry (LCMS). Peaks
with the same mass and retention time as ascarosides C6, C9, and
C7 were present in the worm and conditioned medium extracts
from the wild-type cultures, but were absent in the worm and
conditioned medium extracts from the daf-22 and dhs-28 cultures
(Fig. S2 A and data not shown). In addition, analysis by double
quantum filtered (dqf)-COSY NMR confirmed the presence of
the ascarosides, including C3 (which could not be detected by
LCMS), in the wild-type worm and conditioned medium extracts
Butcher et al.

and their absence in the daf-22 and dhs-28 worm and conditioned
medium extracts (Fig. S2B and data not shown).
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Characterization of Long-Term Cultures of daf-22 and dhs-28 Worms.
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Dauer Pheromone Biosynthesis in the Intestine by DAF-22. DAF-22

bears the canonical peroxisomal targeting signal, SKI, at its C
terminus. To study the expression pattern and intracellular
localization of DAF-22, we generated transgenic animals that
expressed a DAF-22 fusion protein that was tagged with green
fluorescent protein (GFP) at its N terminus, under the control
of the native daf-22 promoter. The GFP-DAF-22 protein is
strongly expressed in the intestine, the hypodermis, and the body
Butcher et al.

Intestine

wall muscle at all developmental stages (Fig. 3) and this expression pattern is shared by dhs-28 (data not shown). The punctate
signal is consistent with peroxisomal targeting of the GFPDAF-22 fusion protein. Furthermore, GFP-DAF-22 was retained in the cytoplasm when transgenic animals were subjected
to prx-5 RNAi, which disrupts import of peroxisomal proteins
(28) (data not shown).
To determine the tissue in which daf-22 is required for dauer
pheromone biosynthesis, we expressed GFP-DAF-22 under the
control of its native promoter or an intestine-specific promoter
(vha-6). The 2 transgenic lines were grown in liquid culture, and
the conditioned medium was collected, freeze-dried, and extracted with ethanol. Titration of the extracts in the dauer
formation assay indicated that transgenic expression of DAF-22
in the intestine (compared with transgenic expression of DAF-22
under the control of the native promoter) was sufficient to
restore production of a significant amount of dauer-inducing
activity (16 ⫾ 3% vs. 53 ⫾ 9% dauers). Ascaroside C6, C9, and
C3 were present in the extracts, as judged by LCMS and
dqf-COSY analysis (Fig. S5). Therefore, the intestine is most
likely the major site where dauer pheromone is synthesized.
Discussion
The biosynthesis of the active dauer pheromone components,
ascarosides C6, C9, and C3, requires 2 genes involved in fatty
acid ␤-oxidation, daf-22, a homolog of human SCPx thiolase, and
dhs-28, a homolog of the human D-bifunctional protein. In
humans, ␤-oxidation occurs in both the mitochondria and the
peroxisomes. Mitochondrial ␤-oxidation degrades short-chain
(⬍C8), medium-chain (C8-C12), and long-chain (C14-C20) fatty
acids to acetyl-CoA for the generation of energy. Peroxisomal
␤-oxidation, however, degrades long- and very-long (⬎C20)chain fatty acids to medium-chain fatty acids for subsequent
export to the mitochondria and occurs through both inducible
and noninducible pathways (27). SCPx and D-bifunctional protein are involved in the noninducible pathway in the peroxisome
and catalyze the ␤-oxidation of straight-chain and branchedchain fatty acyl-CoAs and bile acid intermediates. The requirement for DAF-22 and DHS-28 in the production of the dauer
pheromone suggests that in C. elegans pheromone production
and thus developmental decisions are closely coupled to basic
metabolic pathways in the peroxisomes.
The daf-22 and dhs-28 cultures latently accumulate ascarosides with long-chain fatty acid side chains, stalled at different
stages in the ␤-oxidation process. These long-chain ascarosides
may be intermediates in the dauer pheromone biosynthetic
pathway. The long-chain ascarosides appear to accumulate in
both the worms and in the culture media, but it is unclear
whether the long-chain ascarosides are actively secreted/
excreted from the worms or whether they are released on the
death and eventual lysis of the worms. Earlier work suggested
PNAS 兩 February 10, 2009 兩 vol. 106 兩 no. 6 兩 1877
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Fig. 3. Localization of the DAF-22 using a DAF-22 fusion protein tagged with
GFP at its N terminus, the expression of which is under the control of the native
daf-22 promoter. An L1 animal is shown.
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Prolonged culturing of daf-22 worms has previously been shown
to result in active conditioned medium that can be used to block
dauer recovery (24). To characterize the active molecules in
long-term cultures, wild-type, daf-22, and dhs-28 worms were
grown in liquid culture for an additional 10 d after the food had
been exhausted (for a total duration of 20 d). The worms were
filtered from the conditioned medium and washed, and both the
worms and the conditioned medium were collected, freeze dried,
and extracted with ethanol. The worm and conditioned medium
extracts obtained from the daf-22 and dhs-28 cultures both
showed dauer-inducing activity in a dauer formation assay (Fig.
2B). In particular, the activity of the conditioned medium from
the dhs-28 culture approached that of the conditioned medium
from the wild-type culture. LCMS and dqf-COSY analysis of the
worm and conditioned medium extracts from the long-term
daf-22 and dhs-28 cultures showed that ascarosides C6, C9, C3,
and C7 were not present (Fig. S3 and data not shown).
To characterize the molecules responsible for this activity, we
fractionated in parallel the conditioned medium and worm
extracts from the long-term wild-type, daf-22, and dhs-28 cultures by high-pressure liquid chromatography (HPLC) and analyzed the activity of the fractions in the dauer formation
assay. As indicated by their elution time, the active fractions
from worm and media extracts from the daf-22 and dhs-28
cultures are of similar polarity and are less polar than the active
fractions from the extracts from the wild-type cultures. Analysis
of the dhs-28 conditioned medium active fractions by dqf-COSY
and high-resolution mass spectrometry (HRMS) indicated that
the active molecules are complex mixtures of ascaroside derivatives with longer-chain fatty acids that appear to be stalled at
different steps in the ␤-oxidation pathway. The side chains of the
longer-chain ascarosides present in the dhs-28 conditioned medium active fractions include ␣,␤-unsaturated fatty acids (5-8),
␤-hydroxyl fatty acids (13–16), a ␤-keto fatty acid (17), as well as
unusual ␤,␥-unsaturated fatty acids (9-12) (Fig. 2C; see Fig. S4
and Tables S1–S4 for NMR data and Materials and Methods for
HRMS data). There was some degree of culture-to-culture
variation in the molecules that were present. For comparison,
ascaroside C9 is similar in structure to 5 through 8, but with n ⫽
1. The daf-22 conditioned medium active fractions also appeared
to contain long-chain ascarosides, based on the presence of
characteristic peaks in the dqf-COSY spectrum, although these
ascarosides were not present in sufficient quantities for further
characterization (data not shown). None of the long-chain
ascarosides (5–17) were detected in wild-type conditioned medium, as judged by LCMS. To verify the structural assignments
of the long-chain ascarosides, a representative long-chain ascaroside (6) was synthesized (see SI Methods), and its polarity (as
judged by its LCMS retention time) and dqf-COSY NMR
spectrum were shown to be identical to that of natural 6 (Table
S1). The EC50 of 6, when assayed in parallel with ascaroside C9
in the dauer formation assay at 25 °C, was 2.7 M, compared
with 820 nM for ascaroside C9, indicating that an ascaroside with
a longer ␣,␤-unsaturated fatty acid side chain is somewhat less
potent than ascaroside C9, but still retains significant activity.

Downloaded at TROY H MIDDLETON LIBRARY on December 1, 2021

that dauer-inducing activity could be extracted from actively
growing daf-22 worms by lysing them in aqueous buffer (24) and
incubating the extract at room temperature for prolonged periods of time (D. Riddle, personal communication). We have been
able to repeat these results, but we only obtain activity after
incubating the extract at room temperature for ⬇2 weeks, and
even then we often do not obtain any activity for unknown
reasons (data not shown). Thus, it is likely that the compounds
present in the initial daf-22 worm extract are not active, but must
instead be modified either enzymatically or nonenzymatically
over time to become active. It is possible that long-chain
ascarosides are responsible for the dauer-inducing activity in the
aged daf-22 worm lysate and that the same processes that enable
long-chain ascarosides to accumulate in daf-22 worms on prolonged culturing generate the long-chain ascarosides in the
aqueous lysate. However, we have been unable to confirm this
possibility given the low abundance of the active molecules.
There are at least 2 plausible models for the role of peroxisomal fatty acid ␤-oxidation in the biosynthesis of the dauer
pheromone. In the first model, daf-22 and dhs-28 shorten
long-chain fatty acids to short-chain fatty acids that are subsequently  or -1 hydroxylated and attached to the ascarylose
sugar to generate the dauer pheromone, ascarosides C6, C9, and
C3. The accumulation of the long-chain ascarosides in the
mutant strains may thus be a consequence of the accumulation
of long-chain fatty acids, which are then nonspecifically hydroxylated and attached to the ascarylose sugar over time because
of the promiscuity of the enzymes involved. In the second
model, daf-22 and dhs-28 shorten long-chain ascarosides through
␤-oxidation to generate the dauer pheromone, ascarosides C6,
C9, and C3. The presence of the long-chain ascarosides in the
mutant strains may thus represent the accumulation of upstream
intermediates in the dauer pheromone biosynthetic pathway.
Interestingly, there is some evidence for the presence of very
long-chain ascarosides in nematodes; they have been isolated
from the internal lipid layer of the eggs of a range of nematode
species (29, 30), where they provide a highly resistant barrier that
protects the eggs from chemical treatments (31, 32). Typically,
the side chains of these ascarosides are 32–34 carbons in length,
and are either C-2 monols or C-2, -1 diols. Furthermore, SCPx
thiolase and D-bifunctional protein have been shown to process
bulky substrates such as bile acids, and thus, their C. elegans
homologs DAF-22 and DHS-28 could potentially process a bulky
long-chain ascaroside.
Both daf-22 and dhs-28 are expressed primarily in the intestine, suggesting that the ascarosides are produced in the intestine. Furthermore, expression of daf-22 in the intestine is
sufficient to restore the production of ascarosides C6, C9, and
C3. It is possible that the worms excrete rather than secrete the
ascarosides. It is unclear why transgenic expression of DAF-22
is not sufficient to restore all dauer-inducing activity to the
conditioned medium, given that it is able to restore production
of ascarosides C6, C9, and C3. However, it is possible that
DAF-22 expression in tissues other than the intestine is required
for the production of some as-yet-unidentified dauer-inducing
ascaroside.
Dauer pheromone biosynthesis in C. elegans is coupled to peroxisomal fatty acid ␤-oxidation. Thus, the dauer pheromone may
reflect the metabolic activity of a population, not just the population density, and therefore may provide information to the animals
regarding nutrient availability—another determinant for dauer
arrest. Our findings suggest how the flux of fat metabolism may be
translated into environmental signals (the dauer pheromone ascarosides) that govern reproductive development of a population of
animals. Further study of dauer pheromone biosynthetic pathways
will provide additional insights into the control mechanisms for
dauer pheromone production.
1878 兩 www.pnas.org兾cgi兾doi兾10.1073兾pnas.0810338106

Materials and Methods
Strains and General Culture Methods. All strains were maintained at room
temperature on NGM agar plates, which were made with granulated agar (BD
Biosciences) and seeded with OP50 bacteria.
General Chemical Procedures. NMR spectra of all natural compounds were
recorded on a Varian VNMRS 600 NMR (600 MHz for 1H, 151 MHz for 13C).
HRMS data for natural compounds were obtained on a Q-TOF-2 spectrometer
(Micromass), equipped with an Alliance 2690/2695 HPLC system (Waters).
Genetic Screen. Wild-type N2 animals were mutagenized with ethyl methanesulfonate (EMS) by using standard procedures. F2 progeny from mutagenized
animals were grown on plates with C1-BODIPY-C12 (Invitrogen, D-3823), and
adult animals that showed altered staining were selected. We screened 36,000
haploid genomes and retrieved mutants in 4 complementation groups. Genetic mapping was performed based on a SNP-based mapping strategy by
crossing the mutants with the Hawaiian C. elegans isolate CB4856 (33). We
mapped hj1 to LGII (uCE2–2131) and noted that animals bearing hj1 shared the
same abnormal C1-BODIPY-C12 staining phenotype as the deletion mutant
Y57A10C.6(ok693), which we studied in an independent survey of thiolase
mutants. We isolated genomic DNA from animals bearing hj1, hj2, hj3, and hj4
and identified missense mutations in Y57A10C.6 in all cases by sequencing.
Because Y57A10C.6 resides in the same genetic interval as daf-22, which also
displays abnormal C1-BODIPY-C12 staining phenotype, we sequenced
Y57A10C.6 in animals bearing the canonical daf-22 allele, m130, and found
that it was identical to hj4. The daf-22p::gfp::daf-22 transgene rescued both
the Daf-d and abnormal fat storage phenotypes of daf-22(ok693). We
mapped hj5 to LGX between SNPs pkP6154 and pkP6155. Of the candidate
genes we sequenced in this interval, we found mutations in dhs-28 in hj5, hj6,
hj7 and hj8. All analysis on dauer pheromone was performed by using daf22(ok693) and dhs-28(hj8).
Preparation of Conditioned Medium and Worm Extracts. Crude dauer pheromone extract was prepared essentially according to the method of Golden and
Riddle (2, 20); 4.5 L of worms were cultured in 4-L flasks (1.5 L per flask) for 10 –20
d at 22.5 °C on a rotary shaker. Of saturated OP50, 4.5 L was resuspended in a
small volume of S medium and half was added as a food source at day 1 and half
at day 6. Conditioned medium was filtered through Whatman paper, and worms
were collected from the paper by using distilled water. The worms were washed
once and freeze-dried. The filtered conditioned medium was centrifuged to
remove any remaining worms and freeze dried. The freeze-dried conditioned
medium was pulverized by using a mortar and pestle, and the freeze-dried worms
were pulverized with sodium chloride also by using a mortar and pestle. The
freeze-dried conditioned medium and worms were extracted with 95% aqueous
ethanol (0.45 L ⫻ 3) to afford conditioned medium and worm extracts. These
extracts were then dried down, dissolved in 3 mL of methanol, filtered through
cotton, and either analyzed by LCMS or dried down again and resuspended in 1
mL of CD3OD for dqf-COSY analysis.
Dauer Formation Assay. The dauer formation assay was performed as described (22) by using plates made with Noble agar (BD Biosciences).
Analysis of the Long-Chain Ascarosides. The wild-type, daf-22(ok693), and
dhs-28(hj8) worm and conditioned medium extracts were fractionated directly by reversed phase HPLC on a C18 column (Supelco) by using an aqueous
acetonitrile gradient (10 –100%). Active fractions were identified by using the
dauer formation assay and were characterized by dqf-COSY (see Fig. S4 and
Tables S1–S4) and HRMS. HR-ESIMS (m/z): [M⫹Na]⫹ calculated for C18H32O6Na
(5,9) 367.2097, found 367.2113; HR-ESIMS (m/z): [M⫹Na]⫹ calculated for
C19H34O6Na (6,10) 381.2253, found 381.2255; HR-ESIMS (m/z): [M⫹Na]⫹ calculated for C20H36O6Na (7,11) 395.2410, found 395.2419; HR-ESIMS (m/z):
[M⫹Na]⫹ calculated for C21H38O6Na (8,12) 409.2566, found 409.2578; HRESIMS (m/z): [M⫹Na]⫹ calculated for C20H38O7Na (13) 413.2515, found
413.2528; HR-ESIMS (m/z): [M⫹Na]⫹ calculated for C21H40O7Na (14) 427.2672,
found 427.2667; HR-ESIMS (m/z): [M⫹Na]⫹ calculated for C22H42O7Na (15)
441.2828, found 441.2833; HR-ESIMS (m/z): [M⫹Na] ⫹ calculated for
C23H44O7Na (16) 455.2985, found 455.3013; HR-ESIMS (m/z): [M⫹Na]⫹ calculated for C22H40O7Na (17) 439.2672, found 439.2679.
Synthesis of Long-Chain Ascaroside, 6. Experimental details regarding the synthesis of 6, as well as full characterization of synthetic intermediates and 6, can
be found in SI Methods. Because natural 6 was isolated as a salt, synthetic 6 was
converted to the salt (by addition of a 2-fold molar excess of sodium hydroxide) before comparative analysis with natural 6 by dqf-COSY (see Table S1).
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Transgenic Expression of daf-22. All constructs are based on the pPD49.26
vector from Andy Fire that was modified by Jihong Bai. For
daf-22p::gfp::daf-22, the 2.3-kb daf-22 promoter was amplified by PCR by
using 5⬘-atatgcatgcatggctttaccaccaattgtaac-3⬘ and 5⬘-atatcccgggttttctggaacaatatttttttttcg-3⬘ and subcloned via SphI/SmaI sites. The daf-22 coding sequence and 3⬘ UTR was amplified by PCR by using 5⬘-aaatgcggccgctacgccaaccaagccaaaggtat-3⬘ and 5⬘-tatagctagcagttagttttttactagaagctg-3⬘ and
subcloned via NotI/NheI sites. For vha-6p::gfp::daf-22, the vha-6 promoter was
amplified by PCR by using 5⬘-gccagcatgctcaacgttgccagtga-3⬘ and 5⬘-
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CHEMISTRY

aaatggatcctttttatgggttttggtaggttttagtc-3⬘ and subcloned via SphI/BamHI
sites. The daf-22 cDNA was amplified by PCR by using 5⬘-aaatgcggccgctacgccaaccaagccaaaggtat-3⬘ and 5⬘-aaatgctagctcaaatcttggactgtgcag-3⬘ and subcloned via NotI/NheI sites. All transgenic lines were established by injecting the
daf-22 constructs at 2 ng/L, ttx-3::dsRed at 30 ng/L, and pBluescript at 68
ng/L into daf-22(ok693) mutant animals.

GENETICS

Data Analysis. EC50 values were determined by using Prism software. Each
titration curve was fit with a sigmoidal curve with variable slope, in which the
lower limit was set at 0 and the upper limit was not defined. The EC50 was
defined as the concentration at which each ascaroside reached half its maximal activity (as calculated by Prism).

